📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma. (2014)

First Author: Corradi M

Attributed to: Biomedical Catalyst – Smart Combination Respiratory Medicines for Optimal & Cost Effective Patient Benefit funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1517/17425247.2014.928282

PubMed Identifier: 24921434

Publication URI: http://europepmc.org/abstract/MED/24921434

Type: Journal Article/Review

Volume: 11

Parent Publication: Expert opinion on drug delivery

Issue: 9

ISSN: 1742-5247